Carotuximab (DE-122) is a novel endocholine antibody with strong antiangiogenic and anti-inflammatory activity. Carotuximab blocks endothelial glycoprotein (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antitumor
CAS Number:
[1268714-50-6]
Target:
TGF-beta/Smad|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted